These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 13753032)
41. How bradykinin alters the lipid membrane structure: a spin label comparative study with bradykinin fragments and other cations. Turchiello RF; Juliano L; Ito AS; Lamy-Freund MT Biopolymers; 2000 Sep; 54(3):211-21. PubMed ID: 10861382 [TBL] [Abstract][Full Text] [Related]
42. Cis-trans isomerizations of proline residues are key to bradykinin conformations. Pierson NA; Chen L; Russell DH; Clemmer DE J Am Chem Soc; 2013 Feb; 135(8):3186-92. PubMed ID: 23373819 [TBL] [Abstract][Full Text] [Related]
43. A kinetic comparison of the homologous proteases astacin and meprin A. Wolz RL Arch Biochem Biophys; 1994 Apr; 310(1):144-51. PubMed ID: 8161197 [TBL] [Abstract][Full Text] [Related]
44. Identification of endogenous Des-Arg9-[Hyp3]-bradykinin in human plasma with post-source-decay matrix-assisted laser desorption/ionization mass spectrometry. Schlüter H; Mentrup D; Gross I; Meyer HE; Spengler B; Kaufmann R; Zidek W Anal Biochem; 1997 Mar; 246(1):15-9. PubMed ID: 9056177 [TBL] [Abstract][Full Text] [Related]
45. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung. Ercan ZS; Bor NM; Torunoğlu M; Türker RK Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and activity of dimeric bradykinin antagonists containing diaminodicarboxylic acid bridge residues. Lange M; Cuthbertson AS; Towart R; Fischer PM J Pept Sci; 1998 Jun; 4(4):289-93. PubMed ID: 9680062 [TBL] [Abstract][Full Text] [Related]
47. Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin. Takada Y; Skidgel RA; Erdös EG Biochem J; 1985 Dec; 232(3):851-8. PubMed ID: 3937523 [TBL] [Abstract][Full Text] [Related]
48. Synthesis of peptides by the solid-phase method. IV. Des-Arg(9)-bradykinin and analogs. St-Pierre S; Gaudreau P; Drouin JN; Regoli D; Lemaire S Can J Biochem; 1979 Aug; 57(8):1084-9. PubMed ID: 540245 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate. Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537 [TBL] [Abstract][Full Text] [Related]
50. Purification and cardiovascular activity of [Met1, Met5]-bradykinin from the plasma of a sturgeon (Acipenseriformes). Li Z; Smith MP; Duff DW; Barton BA; Olson KR; Conlon JM Peptides; 1998; 19(4):635-41. PubMed ID: 9622017 [TBL] [Abstract][Full Text] [Related]
51. Natural and synthetic bradykinin. LEWIS GP Nature; 1960 Dec; 188():999. PubMed ID: 13761709 [No Abstract] [Full Text] [Related]
52. Anti-inflammatory property of 401, a peptide from the venom of the bee (Apis mellifica L). Hanson JM; Morley J; Soria C Br J Pharmacol; 1972 Nov; 46(3):537P-538P. PubMed ID: 4656623 [No Abstract] [Full Text] [Related]
53. [On circulatory effects of synthetic bradykinin in man and waking dogs]. GERSMEYER EF; SPITZBARTH H Klin Wochenschr; 1961 Dec; 39():1227-33. PubMed ID: 13898078 [No Abstract] [Full Text] [Related]
54. Maurício Rocha e Silva MD: snake venom, bradykinin and the rise of autopharmacology. Hawgood BJ Toxicon; 1997 Nov; 35(11):1569-80. PubMed ID: 9428104 [TBL] [Abstract][Full Text] [Related]
55. Actions of pure bradykinin. ELLIOTT DF; HORTON EW; LEWIS GP J Physiol; 1960 Oct; 153(3):473-80. PubMed ID: 13726429 [No Abstract] [Full Text] [Related]
56. Synthesis and biological properties of L-arginyl-Lprolyl-glycyl-L-phenylalanyl-L-seryl-L-phenylalanyl-L-arginine, an octapeptide related to bradykinin. NICOLAIDES ED; DEWALD HA; SHORLEY PG; COLLIER HO Nature; 1960 Aug; 187():773-4. PubMed ID: 14426973 [No Abstract] [Full Text] [Related]